The Myeloma Diagnosis Pathway is an easy to follow, quick reference tool to help GPs and other healthcare professionals recognise the signs and symptoms of myeloma. It provides information on which tests and investigations should be conducted before referral to a haematologist. It has been designed by Myeloma UK and reviewed by a working group…
Common Terminology Criteria for Adverse Events (CTCAE) is widely accepted as the standard classification and severity grading scale for adverse events in cancer therapy, clinical trials and other oncology settings. Version 5.0 is the most updated document (November 27, 2017)
This document explains the aims of the Myeloma UK Nursing Best Practice Guides and how they should be used to enhance knowledge and inform nursing practice thus enabling nurses to deliver the highest possible treatment, care and support to myeloma patients and their families.
The purpose of this Guide is to enhance knowledge and inform nursing practice when providing psychological support to myeloma patients.